We are live on ! Find out more
PAVMW

PAVmed Inc. Warrant
PAVMW

Delisted

PAVMW was delisted on the 28th of January, 2022.

Back to rankings

2 hedge funds and large institutions have $1K invested in PAVmed Inc. Warrant in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.23K
2
AF
Allworth Financial
California
+$324

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$1K +$1.23K +1,518 New
AF
2
Allworth Financial
California
– +$324 +400 New

PAVMW Hedge Fund Activity: Q1 2020 in Review

2 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q1 2020, worth a combined $1K.

Buyers outnumbered sellers: 2 funds opened new PAVMW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $1.23K.

  • 2 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q1 2020, up from 0 in Q4 2019.
  • Funds reported $1K of PAVmed Inc. Warrant stock for Q1 2020.
  • 2 funds opened new PAVmed Inc. Warrant positions in Q1 2020 and 0 closed out, a net change of +2 holders.
  • The largest PAVmed Inc. Warrant buyer in Q1 2020 was UBS Group, an estimated $1.23K added.

Based on aggregated 13F filings for Q1 2020.